Home > NYMC > Students > Quill & Scope
Abstract
Modern cancer immunotherapy is the reemergence of an old field striving to use the body’s immune system to target cancer. Though cancer subverts the innate and adaptive immune systems, various non-cellular and cellu-lar based therapies have been developed to overcome these mechanisms. The variety of these techniques and their potential in the treatment of cancer has been a truly exciting development in medicine.
Recommended Citation
Karsy, M., & England, B. (2013). Cancer Immunotherapy Comes of Age. Quill & Scope, 6 (1). Retrieved from https://touroscholar.touro.edu/cgi/viewcontent.cgi?article=1150&context=quill_and_scope